Cipla Quality Chemical Industries Ltd
Colline Mambule Sekitoleko has a diverse work experience. In 2020, they worked as a Chief Data Scientist at Cipla Quality Chemical Industries Ltd. They also worked as a Networking Specialist at family best products and a Data Scientist at K. D. GROUP OF COMPANIES in 2022. Additionally, Colline had the role of a Gospel Disco at Gospel Disco, where music glorifies God, starting from 2017. In 2021, they served as a Data Scientist at kingdavid group of companies. Prior to that, Colline worked as a Transport officer at Emerald hearts ministries from 2018 until 2020.
Colline Mambule Sekitoleko's education history is as follows:
From 2018 to 2021, Colline attended Makerere University, where they pursued a degree in Computer Networking with a focus on Information Technology.
In 2018, Colline also enrolled at Suffolk University and pursued a degree in ICT networking, which they completed in 2021.
In 2019, Colline joined IU International University of Applied Sciences, where they pursued a Bachelor's degree in Data Science and Analytics. They completed this degree in 2022.
During this time, Colline also pursued another Bachelor's degree in Data Science and Analytics at IU International University of Applied Sciences, which they completed in 2022.
Currently, Colline is enrolled at IU International University of Applied Sciences, pursuing a Master's degree in Data Science and Analytics since 2021.
Additionally, in 2022, Colline attended St. Augustine University of Tanzania and completed a Certificate in Sales and Marketing. The field of study for this certificate was Sales, Distribution, and Marketing Operations, General.
This person is not in any teams
Cipla Quality Chemical Industries Ltd
Cipla Quality Chemical Industries Limited has a state-of-the-art pharmaceutical manufacturing plant located in Kampala, Uganda primarily manufacturing antiretroviral drugs (ARVs) and artemisinin-based combination therapies (ACTs) to combat HIV/AIDS and Malaria respectively. The company was founded in June 2005 as a joint venture between Quality Chemicals Limited (QCL), a private limited company incorporated in Uganda for the importation and distribution of pharmaceutical drugs, and Cipla Ltd, a leading Indian pharmaceutical company. The joint venture then attracted Capitalworks and TLG Capital Investment each with a vision to have Cipla Quality Chemical Industries Limited a center of pharmaceutical manufacturing excellence in the region. CiplaQCIL is designed to meet the world’s most stringent pharmaceutical regulatory standards and is pre-qualified by the World Health Organization (WHO) as an additional contract manufacturing site for Cipla Ltd’s products.